Seriously Don’t Do That™
Seriously Don’t Do That™ is a weekly show for founders making high-stakes growth decisions and trying not to learn the hard way.
Each episode focuses on one specific mistake founders make under pressure: U.S. market entry assumptions, emotional beachhead choices, premature sales hires, ICP chaos, compliance blind spots, broken pipelines, and board-level credibility gaps.
Hosted by Dan Griffith, the show brings pattern recognition from real founder situations across healthcare, fintech, insurance, and other regulated or institutionally complex markets. Guest episodes validate the reality. Dan explains what actually went wrong and what to do instead.
This isn’t hustle content. It’s not tactics without context. And it’s not agency advice.If growth feels harder than it should… you’re probably right.
Seriously, Don’t Do That!
Episodes
64 episodes
Seriously Don't Hire a Distributor and Call Latin America "Covered" with Franklin J. Perez
So, most founders think Latin America is one market with one playbook. It's not. And the part that surprises people most? The first move isn't picking a country — it's picking a channel strategy.In this episode, Dan sits down with Frankl...
Don't Map Just the Champion | Map the Whole Buying Committee
In this tactical episode of Seriously Don't Do That™ — Week 3 of the 12-week SDDT program and Episode 3 of the ICP Sprint month — Dan Griffith breaks down the single most common (and most expensive) mistake founders make in regulated B...
Your ICP Is Probably Aspirational, Not Real | Build It From Evidence
Dan just got back from training for a sprint triathlon and realized something uncomfortable - he's not the athlete he thinks he is anymore. The video doesn't lie. The times don't lie. And that gap between who you think you are and who you actua...
The Costliest ICP Mistake Founders Make in Regulated B2B Markets
Welcome to Week 1 of a brand new 12-week run of Seriously Don't Do That™. We're opening with ICP Month - four episodes on your ideal customer, why they buy, and the choices you have to make to actually grow.This is the episode Dan pr...
Seriously, Don’t Enter the U.S. Without Testing the Playbook | Todd Jenkins, VP Revenue at Codility
A seasoned British sales leader walks into his first U.S. meeting. No deck. No slides. Just ready to have a conversation. The buyer’s response? “Where’s your deck? You came unprepared.”In this episode of Seriously Don’t Do ...
The U.S. Entry Trap, Assuming It's Just Bigger and Works Like Home
Founders entering the U.S. often do everything “right”, strong product, great meetings, smart people and still go nowhere.In this episode of Seriously Don’t Do That™, Dan Griffith sits down with Geir Arnhoff, founder of Dossier, to brea...
Seriously Don't Skip Your Back Office Setup
Entering the U.S. market isn’t just a sales problem.It’s an operational one.In this episode of Seriously Don’t Do That, Dan Griffith sits down with Sims Tullos of Amesto Global to break down the back-office mistakes that quietly der...
The Half-Million Dollar Mistake: Stop Funding the Wrong Things
Entering the U.S. market is not a spending problem — it’s a sequencing problem.Every year, European SaaS and healthtech founders burn six figures on activities that feel productive but don’t create pipeline:• Conference booths befor...
Seriously Don’t Wing It at Trade Shows | Ben Griffith
Most founders walk into trade shows hoping for visibility and walk out with nothing more than badge scans, swag bags, and zero pipeline.The issue isn’t the booth.It’s the missing system behind it.In this 45-minute session, I...
Who Really Signs the Check? Selling Healthtech in the U.S. Market
Most founders don’t lose U.S. deals because of their product…they lose because they pitch to the wrong person.And that’s exactly what we’re breaking down live this week.If you're building or selling in healthtech and you sti...
Seriously Don't Hire Your US Sales Team First: Why Infrastructure Beats Headcount
You’ve raised capital and your board wants traction in the US market. The gut reaction? Hire a top-notch VP of Sales immediately. But what if that move actually slows you down?In this practical 30-minute live event, Dan Griffith will un...
Who Really Signs the Check? Selling Healthtech in the U.S. Market
Most founders don’t lose U.S. deals because of their product…they lose because they pitch to the wrong person.And that’s exactly what we’re breaking down live this week.If you're building or selling in healthtech and you sti...
Seriously Don't Skip the Process Work: Why Your CRM Is Lying to You
Join me on Thursday, October 16th at 9AM EDT for a 30-minute live session where we strip back the buzz and get real about what makes a growth pipeline trustworthy or doomed to fail. Founders too often spend big on branding, sales hiring, and ou...
Seriously, Don't Pay 5 Figures for Fancy Fonts and Crappy Leads
Spend 5 figures on slick fonts, fancy decks, and noisy agencies or spend that same $$$ to own your Go-to-Market engine? If your GTM strategy feels rented, you’re not alone and it’s time to change that. No marketing fluff. Just clear steps to di...
Seriously, Don't Hire a BDR in 2026
An exclusive 30-minute session tailored for founders and sales leaders struggling with the costly hire-fire cycles in outbound sales.In "Seriously, Don't Hire a BDR in 2026," we dive deep into why traditional BDR models are failing star...
Board-Ready Revenue: Stop Guessing, Start Knowing
Board-Ready Revenue: Stop Guessing, Start KnowingHow to walk into Q4 planning with data you can defendIn this focused 30-minute session, Dan explores why boards lose confidence when founders rely on presentations over real data. The...
Seriously Don’t Launch Blind in 2026
A focused 30-minute session designed especially for founders ready to break into new markets without wasting precious time and money.We’ll dive into the story of three founders across different countries who faced the same challenge: sm...
The $750K Marketing Machine That Closed Zero Deals
The $750K Marketing Machine That Closed Zero Deals – How to Stop Confusing Activity with StrategyToo many founders mistake activity for strategy—tracking clicks, opens, and MQLs, without generating qualified opportunities or revenue. In...
Don't Skip the Foundations: Are You Really Ready for the US Market?
Are you rushing into the US market without the right foundations? That $1.5M price tag from a London boardroom disaster could be yours if you don’t get this right.Join me LIVE as I will share the four critical foundations that every com...
Don't Hire a Marketing Team Before You Have an AI-Amplified GTM Strategy
"I heard this three times last week: 'We're about to hire 6 people for go-to-market — Marketing manager, SDRs, inside sales rep, content creator…' Different founders, same $500K mistake.The issue wasn’t the ...
Seriously, Don’t Confuse Looking Big with Getting Customers
Many post-Series A founders burn precious runway trying to look big; new branding, PR campaigns, flashy awareness plays while their pipeline stays empty.But here’s the truth: revenue doesn’t come from looking the part. It comes from get...
Seriously, Don’t Ignore AI’s Impact on Customer Success
Most SaaS founders celebrate new sales — but if your post-sale bucket is leaking, those logos won’t save you.In this episode, Dan Griffith sits down with Jason Noble, Co-founder and Co-host of The Jasons Take On po...
Seriously, Don’t Treat Marketing Like a Side Hustle
You're not imagining it, your pipeline's dry because you're too busy for marketing.And you're not alone.❌ 36% of founders spend most of their time on admin❌ 33% wish they had more time for marketing❌ Most don’t realize how m...
Seriously, Don’t Guess What’s in Your Pipeline
🎙️ Podcast Episode: "Seriously, Don’t Guess What’s in Your Pipeline"Think you have a sales problem? You might actually have a pipeline delusion.Dan once forecasted $10M in deals... and closed just $100K. Sound fami...
Seriously, Don't Raise Venture Capital Until You Know Your Real Options
Seriously, Don’t Raise Venture Capital Until You Know Your Real Options”Too many founders default to VC funding without understanding the full menu of capital options — and it costs them equity, control, and leverage.In thi...